miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance
- PMID: 35672774
- PMCID: PMC9172103
- DOI: 10.1186/s12967-022-03422-7
miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance
Abstract
Objective: Ovarian cancer (OC) is a major threat to women's health. Mesenchymal stem cells (MSCs) are key regulators in cellular communication by secreting extracellular vesicles (EVs) that are involved in OC. This study probed into the mechanism of human MSCs derived-EVs (hMSC-EVs) in regulating OC cell growth and chemotherapy resistance.
Methods: hMSCs and EVs were isolated and identified. After adding EVs, the uptake of EVs by OC CAOV3/ES2 cells (for in vitro studies), and cell proliferation, migration, and invasion were detected. Downregulated miRNAs in hMSC-EVs were screened and miR-18a-5p expression in OC patients was detected. The prognosis of OC patients was analyzed. Binding sites of miR-18a-5p and NACC1 were predicted and validated. NACC1 expression in OC tissues was measured by RT-qPCR, and its correlation with miR-18a-5p was analyzed by Pearson method. AKT/mTOR pathway activation was assessed by WB. The cisplatin sensitivity of EVs-treated CAOV3 cells was evaluated via MTT assay and tested by tumor formation assay in nude mice.
Results: hMSC-EVs suppressed OC cell proliferation, migration, and invasion. miR-18a-5p was downregulated in OC and miR-18a-5p low expression was associated with a poor prognosis. EV-encapsulated miR-18a-5p targeted NACC1. NACC1 was upregulated in OC tissues. miR-18a-5p knockdown and NACC1 overexpression both annulled the inhibition of hMSC-EVs on OC cell growth. AKT and mTOR were elevated in OC and NACC1 activated the AKT/mTOR pathway in OC cells. hMSC-EVs promoted cisplatin sensitivity of OC cells by carrying miR-18a-5p.
Conclusion: hMSC-EVs-derived miR-18a-5p inhibits OC cell proliferation, migration, invasion, and chemotherapy resistance.
Keywords: AKT/mTOR; Drug resistance; Extracellular vesicles; Mesenchymal stem cells; NACC1; Ovarian cancer.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9172103/bin/12967_2022_3422_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9172103/bin/12967_2022_3422_Fig2_HTML.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9172103/bin/12967_2022_3422_Fig3_HTML.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9172103/bin/12967_2022_3422_Fig4_HTML.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9172103/bin/12967_2022_3422_Fig5_HTML.gif)
![Fig. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9172103/bin/12967_2022_3422_Fig6_HTML.gif)
![Fig. 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9172103/bin/12967_2022_3422_Fig7_HTML.gif)
![Fig. 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9172103/bin/12967_2022_3422_Fig8_HTML.gif)
Similar articles
-
The lncRNA SNHG15/miR-18a-5p axis promotes cell proliferation in ovarian cancer through activating Akt/mTOR signaling pathway.J Cell Biochem. 2020 Dec;121(12):4699-4710. doi: 10.1002/jcb.29474. Epub 2020 Aug 15. J Cell Biochem. 2020. PMID: 33135285
-
miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6.Clin Exp Metastasis. 2022 Aug;39(4):603-621. doi: 10.1007/s10585-022-10165-8. Epub 2022 Apr 21. Clin Exp Metastasis. 2022. PMID: 35449340
-
Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.Biomed Res Int. 2021 Jun 21;2021:6619730. doi: 10.1155/2021/6619730. eCollection 2021. Biomed Res Int. 2021. PMID: 34250088 Free PMC article.
-
Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer.Semin Cancer Biol. 2023 Nov;96:64-81. doi: 10.1016/j.semcancer.2023.10.002. Epub 2023 Oct 10. Semin Cancer Biol. 2023. PMID: 37820858 Review.
-
Liver-derived extracellular vesicles from patients with hepatitis B virus-related acute-on-chronic liver failure impair hepatic regeneration by inhibiting on FGFR2 signaling via miR-218-5p.Hepatol Int. 2023 Aug;17(4):833-849. doi: 10.1007/s12072-023-10513-0. Epub 2023 Apr 13. Hepatol Int. 2023. PMID: 37055701 Review.
Cited by
-
miR-218-5p, miR-124-3p and miR-23b-3p act synergistically to modulate the expression of NACC1, proliferation, and apoptosis in C-33A and CaSki cells.Noncoding RNA Res. 2024 Feb 27;9(3):720-731. doi: 10.1016/j.ncrna.2024.02.016. eCollection 2024 Sep. Noncoding RNA Res. 2024. PMID: 38577025 Free PMC article.
-
Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer.J Clin Invest. 2024 Apr 2;134(10):e176161. doi: 10.1172/JCI176161. J Clin Invest. 2024. PMID: 38564289 Free PMC article. Clinical Trial.
-
Mesenchymal Stem Cell Microvesicles from Adipose Tissue: Unraveling Their Impact on Primary Ovarian Cancer Cells and Their Therapeutic Opportunities.Int J Mol Sci. 2023 Nov 1;24(21):15862. doi: 10.3390/ijms242115862. Int J Mol Sci. 2023. PMID: 37958844 Free PMC article.
-
Protective effect of miR-18a in resected liver metastases of colorectal cancer and FOLFOX treatment.Cancer Rep (Hoboken). 2023 Dec;6(12):e1899. doi: 10.1002/cnr2.1899. Epub 2023 Sep 12. Cancer Rep (Hoboken). 2023. PMID: 37698257 Free PMC article.
-
The Role and Applications of Exosomes in Gynecological Cancer: A Review.Cell Transplant. 2023 Jan-Dec;32:9636897231195240. doi: 10.1177/09636897231195240. Cell Transplant. 2023. PMID: 37632354 Free PMC article. Review.
References
-
- Malander S, Hjerpe E, Carlson J, Borg A. Ovarian cancer is in many ways a heterogeneous disease. Lakartidningen. 2015;112:DIUR. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous